35 employees
Mosaic Biosciences is a developer of synthetic extracellular materials used to support natural tissue regeneration.
2009
$11M
from 4 investors over 4 rounds
Mosaic Biosciences raised $11M on June 14, 2022
Investors: Telegraph Hill Partners
Mosaic Biosciences raised $1M on November 8, 2011
Investors: Morgenthaler, HealthCare Ventures LLC and High Country Ventures